These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 26194182)

  • 1. De novo deleterious genetic variations target a biological network centered on Aβ peptide in early-onset Alzheimer disease.
    Rovelet-Lecrux A; Charbonnier C; Wallon D; Nicolas G; Seaman MN; Pottier C; Breusegem SY; Mathur PP; Jenardhanan P; Le Guennec K; Mukadam AS; Quenez O; Coutant S; Rousseau S; Richard AC; Boland A; Deleuze JF; Frebourg T; Hannequin D; Campion D;
    Mol Psychiatry; 2015 Sep; 20(9):1046-56. PubMed ID: 26194182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. APP, PSEN1, and PSEN2 mutations in early-onset Alzheimer disease: A genetic screening study of familial and sporadic cases.
    Lanoiselée HM; Nicolas G; Wallon D; Rovelet-Lecrux A; Lacour M; Rousseau S; Richard AC; Pasquier F; Rollin-Sillaire A; Martinaud O; Quillard-Muraine M; de la Sayette V; Boutoleau-Bretonniere C; Etcharry-Bouyx F; Chauviré V; Sarazin M; le Ber I; Epelbaum S; Jonveaux T; Rouaud O; Ceccaldi M; Félician O; Godefroy O; Formaglio M; Croisile B; Auriacombe S; Chamard L; Vincent JL; Sauvée M; Marelli-Tosi C; Gabelle A; Ozsancak C; Pariente J; Paquet C; Hannequin D; Campion D;
    PLoS Med; 2017 Mar; 14(3):e1002270. PubMed ID: 28350801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The identification of PSEN1 p.Tyr159Ser mutation in a non-canonic early-onset Alzheimer's disease family.
    Li H; Li Y; Liang W; Wei ZZ; Li X; Tian Y; Qiao S; Yang Y; Yang L; Wu D; Yin W; Liu H; Zhang W; Zhang Y; Wang Z
    Mol Cell Neurosci; 2022 May; 120():103715. PubMed ID: 35247599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening of dementia genes by whole-exome sequencing in early-onset Alzheimer disease: input and lessons.
    Nicolas G; Wallon D; Charbonnier C; Quenez O; Rousseau S; Richard AC; Rovelet-Lecrux A; Coutant S; Le Guennec K; Bacq D; Garnier JG; Olaso R; Boland A; Meyer V; Deleuze JF; Munter HM; Bourque G; Auld D; Montpetit A; Lathrop M; Guyant-Maréchal L; Martinaud O; Pariente J; Rollin-Sillaire A; Pasquier F; Le Ber I; Sarazin M; Croisile B; Boutoleau-Bretonnière C; Thomas-Antérion C; Paquet C; Sauvée M; Moreaud O; Gabelle A; Sellal F; Ceccaldi M; Chamard L; Blanc F; Frebourg T; Campion D; Hannequin D
    Eur J Hum Genet; 2016 May; 24(5):710-6. PubMed ID: 26242991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for Genetic Mutations Associated with Early-Onset Alzheimer's Disease in Han Chinese.
    Liu C; Cong L; Zhu M; Wang Y; Tang S; Han X; Zhang Q; Tian N; Liu K; Liang X; Fa W; Wang N; Hou T; Du Y
    Curr Alzheimer Res; 2022; 19(10):724-733. PubMed ID: 36306459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Novel PSEN1 M139L Mutation Found in a Chinese Pedigree with Early-Onset Alzheimer's Disease Increases Aβ42/Aβ40 ratio.
    Qiu Q; Shen L; Jia L; Wang Q; Li F; Li Y; Jia J
    J Alzheimers Dis; 2019; 69(1):199-212. PubMed ID: 30958370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomics of Alzheimer Disease: A Review.
    Rosenberg RN; Lambracht-Washington D; Yu G; Xia W
    JAMA Neurol; 2016 Jul; 73(7):867-74. PubMed ID: 27135718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel presenilin 1 and 2 double knock-out cell line for in vitro validation of PSEN1 and PSEN2 mutations.
    Pimenova AA; Goate AM
    Neurobiol Dis; 2020 May; 138():104785. PubMed ID: 32032730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic analyses of early-onset Alzheimer's disease using next generation sequencing.
    Giau VV; Bagyinszky E; Yang YS; Youn YC; An SSA; Kim SY
    Sci Rep; 2019 Jun; 9(1):8368. PubMed ID: 31182772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and description of three families with familial Alzheimer disease that segregate variants in the SORL1 gene.
    Thonberg H; Chiang HH; Lilius L; Forsell C; Lindström AK; Johansson C; Björkström J; Thordardottir S; Sleegers K; Van Broeckhoven C; Rönnbäck A; Graff C
    Acta Neuropathol Commun; 2017 Jun; 5(1):43. PubMed ID: 28595629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Copy Number Variants in miR-138 as a Potential Risk Factor for Early-Onset Alzheimer's Disease.
    Boscher E; Husson T; Quenez O; Laquerrière A; Marguet F; Cassinari K; Wallon D; Martinaud O; Charbonnier C; Nicolas G; Deleuze JF; Boland A; Lathrop M; Frébourg T; ; Campion D; Hébert SS; Rovelet-Lecrux A
    J Alzheimers Dis; 2019; 68(3):1243-1255. PubMed ID: 30909216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of Alzheimer beta-amyloid precursor trafficking and metabolism.
    Gandy S; Petanceska S
    Biochim Biophys Acta; 2000 Jul; 1502(1):44-52. PubMed ID: 10899430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PSEN1 mutation carriers present lower cerebrospinal fluid amyoid-β42 levels than sporadic early-onset Alzheimer's disease patients but no differences in neuronal injury biomarkers.
    Balasa M; Vidal-Piñeiro D; Lladó A; Antonell A; Bosch B; Castellanos F; Bargalló N; Bartres-Faz D; Molinuevo JL; Sánchez-Valle R
    J Alzheimers Dis; 2012; 30(3):605-16. PubMed ID: 22426017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of Coding Variability in APP-Aβ Metabolism Genes in Sporadic Alzheimer's Disease.
    Sassi C; Ridge PG; Nalls MA; Gibbs R; Ding J; Lupton MK; Troakes C; Lunnon K; Al-Sarraj S; Brown KS; Medway C; Lord J; Turton J; ; Morgan K; Powell JF; Kauwe JS; Cruchaga C; Bras J; Goate AM; Singleton AB; Guerreiro R; Hardy J
    PLoS One; 2016; 11(6):e0150079. PubMed ID: 27249223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deletion of exons 9 and 10 of the Presenilin 1 gene in a patient with Early-onset Alzheimer Disease generates longer amyloid seeds.
    Le Guennec K; Veugelen S; Quenez O; Szaruga M; Rousseau S; Nicolas G; Wallon D; Fluchere F; Frébourg T; De Strooper B; Campion D; Chávez-Gutiérrez L; Rovelet-Lecrux A
    Neurobiol Dis; 2017 Aug; 104():97-103. PubMed ID: 28461250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new amyloid beta variant favoring oligomerization in Alzheimer's-type dementia.
    Tomiyama T; Nagata T; Shimada H; Teraoka R; Fukushima A; Kanemitsu H; Takuma H; Kuwano R; Imagawa M; Ataka S; Wada Y; Yoshioka E; Nishizaki T; Watanabe Y; Mori H
    Ann Neurol; 2008 Mar; 63(3):377-87. PubMed ID: 18300294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abundance of Aβ₅-x like immunoreactivity in transgenic 5XFAD, APP/PS1KI and 3xTG mice, sporadic and familial Alzheimer's disease.
    Guzmán EA; Bouter Y; Richard BC; Lannfelt L; Ingelsson M; Paetau A; Verkkoniemi-Ahola A; Wirths O; Bayer TA
    Mol Neurodegener; 2014 Apr; 9():13. PubMed ID: 24694184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular systems evaluation of oligomerogenic APP(E693Q) and fibrillogenic APP(KM670/671NL)/PSEN1(Δexon9) mouse models identifies shared features with human Alzheimer's brain molecular pathology.
    Readhead B; Haure-Mirande JV; Zhang B; Haroutunian V; Gandy S; Schadt EE; Dudley JT; Ehrlich ME
    Mol Psychiatry; 2016 Aug; 21(8):1099-111. PubMed ID: 26552589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploring the Role of Aggregated Proteomes in the Pathogenesis of Alzheimer's Disease.
    Narayanan SE; Sekhar N; Rajamma RG; Marathakam A; Al Mamun A; Uddin MS; Mathew B
    Curr Protein Pept Sci; 2020; 21(12):1164-1173. PubMed ID: 32957903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.